🚀 VC round data is live in beta, check it out!
OdontoPrev Valuation Multiples
Discover revenue and EBITDA valuation multiples for OdontoPrev and similar public comparables like Mitra Keluarga, Astrana Health, Almoosa Health, Burjeel Holdings and more.
OdontoPrev Overview
About OdontoPrev
Odontoprev SA is engaged in providing private dental care plans. The firm operates in three segments which include Corporate, Small And Medium-Sized Enterprises, Individual, and other.
Founded
1987
HQ
Employees
N/A
Website
Sectors
Financials (LTM)
EV
$2B
OdontoPrev Financials
OdontoPrev reported last 12-month revenue of $481M and EBITDA of $151M.
In the same LTM period, OdontoPrev generated $298M in gross profit, $151M in EBITDA, and $110M in net income.
Revenue (LTM)
OdontoPrev P&L
In the most recent fiscal year, OdontoPrev reported revenue of $485M and EBITDA of $237M.
OdontoPrev expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $481M | XXX | $485M | XXX | XXX | XXX |
| Gross Profit | $298M | XXX | $175M | XXX | XXX | XXX |
| Gross Margin | 62% | XXX | 36% | XXX | XXX | XXX |
| EBITDA | $151M | XXX | $237M | XXX | XXX | XXX |
| EBITDA Margin | 31% | XXX | 49% | XXX | XXX | XXX |
| EBIT Margin | 29% | XXX | 32% | XXX | XXX | XXX |
| Net Profit | $110M | XXX | $117M | XXX | XXX | XXX |
| Net Margin | 23% | XXX | 24% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
OdontoPrev Stock Performance
OdontoPrev has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
OdontoPrev's stock price is $3.17.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | -0.1% | XXX | XXX | XXX | $0.21 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialOdontoPrev Valuation Multiples
OdontoPrev trades at 3.5x EV/Revenue multiple, and 11.0x EV/EBITDA.
EV / Revenue (LTM)
OdontoPrev Financial Valuation Multiples
As of April 19, 2026, OdontoPrev has market cap of $2B and EV of $2B.
Equity research analysts estimate OdontoPrev's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
OdontoPrev has a P/E ratio of 15.6x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 3.5x | XXX | 3.4x | XXX | XXX | XXX |
| EV/EBITDA | 11.0x | XXX | 7.1x | XXX | XXX | XXX |
| EV/EBIT | 12.1x | XXX | 10.8x | XXX | XXX | XXX |
| EV/Gross Profit | 5.6x | XXX | 9.6x | XXX | XXX | XXX |
| P/E | 15.6x | XXX | 14.8x | XXX | XXX | XXX |
| EV/FCF | 16.7x | XXX | 16.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified OdontoPrev Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
OdontoPrev Margins & Growth Rates
OdontoPrev's revenue in the last 12 month grew by 9%.
OdontoPrev's rule of 40 is 37% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
OdontoPrev's rule of X is 45% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
OdontoPrev Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | 31% | XXX | 49% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | (32%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 37% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 45% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 5% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 4% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
OdontoPrev Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| OdontoPrev | XXX | XXX | XXX | XXX | XXX | XXX |
| Mitra Keluarga | XXX | XXX | XXX | XXX | XXX | XXX |
| Astrana Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Almoosa Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Surgery Partners | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
OdontoPrev M&A Activity
OdontoPrev acquired XXX companies to date.
Last acquisition by OdontoPrev was on XXXXXXXX, XXXXX. OdontoPrev acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by OdontoPrev
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialOdontoPrev Investment Activity
OdontoPrev invested in XXX companies to date.
OdontoPrev made its latest investment on XXXXXXXX, XXXXX. OdontoPrev invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by OdontoPrev
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout OdontoPrev
| When was OdontoPrev founded? | OdontoPrev was founded in 1987. |
| Where is OdontoPrev headquartered? | OdontoPrev is headquartered in Brazil. |
| Is OdontoPrev publicly listed? | Yes, OdontoPrev is a public company listed on B3. |
| What is the stock symbol of OdontoPrev? | OdontoPrev trades under ODPV3 ticker. |
| When did OdontoPrev go public? | OdontoPrev went public in 2006. |
| Who are competitors of OdontoPrev? | OdontoPrev main competitors are Mitra Keluarga, Astrana Health, Almoosa Health, Burjeel Holdings. |
| What is the current market cap of OdontoPrev? | OdontoPrev's current market cap is $2B. |
| What is the current revenue of OdontoPrev? | OdontoPrev's last 12 months revenue is $481M. |
| What is the current revenue growth of OdontoPrev? | OdontoPrev revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of OdontoPrev? | Current revenue multiple of OdontoPrev is 3.5x. |
| Is OdontoPrev profitable? | Yes, OdontoPrev is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of OdontoPrev? | OdontoPrev's last 12 months EBITDA is $151M. |
| What is OdontoPrev's EBITDA margin? | OdontoPrev's last 12 months EBITDA margin is 31%. |
| What is the current EV/EBITDA multiple of OdontoPrev? | Current EBITDA multiple of OdontoPrev is 11.0x. |
| What is the current FCF of OdontoPrev? | OdontoPrev's last 12 months FCF is $100M. |
| What is OdontoPrev's FCF margin? | OdontoPrev's last 12 months FCF margin is 21%. |
| What is the current EV/FCF multiple of OdontoPrev? | Current FCF multiple of OdontoPrev is 16.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.